THCT (THC Therapeutics) YoY EBITDA Growth: 0.00% (As of Jul. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Therapeutics YoY EBITDA Growth?

THC Therapeutics THCT YoY EBITDA Growth is 0.00% as of Jul. 2024.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. THC Therapeutics's YoY EBITDA Growth for the quarter that ended in Jul. 2024 was 0.00%.

THC Therapeutics's EBITDA per Share for the three months ended in Jul. 2024 was $-0.01.

THC Therapeutics YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for THC Therapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics YoY EBITDA Growth Chart

THC Therapeutics Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.99 34.88 25.00 78.57 -111.11

THC Therapeutics Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.00 98.44 -132.69 0.00 0.00

THC Therapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

THC Therapeutics's YoY EBITDA Growth for the fiscal year that ended in Jul. 2024 is calculated as:

YoY EBITDA Growth (A: Jul. 2024 )
=(EBITDA per Share (A: Jul. 2024 )-EBITDA per Share (A: Jul. 2023 ))/ | EBITDA per Share (A: Jul. 2023 ) |
=(-0.019--0.009)/ | -0.009 |
=-111.11 %

THC Therapeutics's YoY EBITDA Growth for the quarter that ended in Jul. 2024 is calculated as:

YoY EBITDA Growth (Q: Jul. 2024 )
=(EBITDA per Share (Q: Jul. 2024 )-EBITDA per Share (Q: Jul. 2023 )) / | EBITDA per Share (Q: Jul. 2023 )) |
=(-0.005--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
THC Therapeutics (THCT) has a YoY EBITDA Growth of 0.00% as of Jul. 2024. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for THC Therapeutics and its competitors.
Is THC Therapeutics' YoY EBITDA Growth too high?
THC Therapeutics' current YoY EBITDA Growth is 0.00%.
How does THC Therapeutics' YoY EBITDA Growth compare to ZTS and UTHR?
THC Therapeutics' YoY EBITDA Growth of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for THC Therapeutics and its competitors. THC Therapeutics's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Therapeutics stock overvalued right now?
THC Therapeutics (THCT) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For THC Therapeutics (THCT), the current YoY EBITDA Growth is 0.00% as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Therapeutics Business Description

Address 203 S Church Steet, Jacksboro, TX, USA, 76458
Website https://thct.io
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.